# Humanigen Inc. (HGEN)

Source: https://www.quantisnow.com/company/HGEN
Generated: 2026-11-14T10:33:05.657Z

- Ticker: HGEN
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- Website: humanigen.com

## About

Humanigen, Inc., a clinical stage biopharmaceutical company, develops a portfolio of immuno-oncology and immunology monoclonal antibodies in the United States. The company's lead product candidate is Lenzilumab, a monoclonal antibody that targets and neutralizes human granulocyte-macrophage colony-stimulating factor, which is in Phase III clinical trial for the treatment of cytokine storm associated with COVID-19; and Phase Ib/II clinical trial as a sequenced therapy in combination with CD19 targeted chimeric antigen receptor T-cell therapies to treat patients with relapsed or refractory B-cell lymphoma, as well as that has completed Phase I clinical trial in patients with chronic myelomonocytic leukemia. It also develops Ifabotuzumab, a humaneered monoclonal antibody that targets EphA3 receptor, which has completed the Phase I dose escalation portion of a Phase I/II clinical trial in multiple hematologic malignancies; and HGEN005, an anti-EMR1 monoclonal antibody, which is in pre-clinical stage for the treatment of eosinophilic disorders. Humanigen, Inc. has a clinical collaboration agreement with Kite Pharma, Inc. to conduct a multi-center Phase Ib/II study of Lenzilumab in patients with relapsed or refractory diffuse large B-cell lymphoma; and a cooperative research and development agreement with the Department of Defense to assist in the development of lenzilumab in advance of a potential emergency use authorization for COVID-19. The company was formerly known as KaloBios Pharmaceuticals, Inc. and changed its name to Humanigen, Inc. in August 2017. Humanigen, Inc. was incorporated in 2000 and is based in Burlingame, California.

## Latest HGEN news and filings

- 2024-01-08 22:02 UTC [SEC Form 8-K] [Humanigen Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/humanigen-inc-filed-sec-form-8-k-entry-into-a-material-5177022)
- 2024-01-05 15:55 UTC [Market Insight] [Humanigen Downfall: FDA Rejection For COVID-19 Drug Triggers Financial Crisis, Bankruptcy](https://www.quantisnow.com/insight/humanigen-downfall-fda-rejection-for-covid-19-drug-triggers-financial-crisis-5172526)
- 2023-10-20 22:50 UTC [SEC Form 4] [Chappell Dale sold $4,250 worth of shares (386,350 units at $0.01) (SEC Form 4)](https://www.quantisnow.com/insight/chappell-dale-sold-4250-worth-of-shares-386350-units-at-5031203)
- 2023-10-12 12:19 UTC [SEC Form 25-NSE filed by Humanigen Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-humanigen-inc-5016593)
- 2023-09-14 20:01 UTC [SEC Form 8-K] [Humanigen Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/humanigen-inc-filed-sec-form-8-k-leadership-update-financial-statements-4971390)
- 2023-08-14 20:05 UTC [SEC Form NT 10-Q filed by Humanigen Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-humanigen-inc-4893717)
- 2023-07-25 18:31 UTC [Market Insight] [Crude Oil Up 1%; Verizon Earnings Beat Views](https://www.quantisnow.com/insight/crude-oil-up-1-verizon-earnings-beat-views-4792456)
- 2023-07-25 17:31 UTC [Market Insight] [12 Health Care Stocks Moving In Tuesday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-tuesdays-intraday-session-4792145)
- 2023-07-25 17:11 UTC [Market Insight] [Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session](https://www.quantisnow.com/insight/why-alaska-air-group-shares-are-trading-lower-by-9-4792046)
- 2023-07-25 16:33 UTC [Market Insight] [Stocks That Hit 52-Week Lows On Tuesday](https://www.quantisnow.com/insight/stocks-that-hit-52-week-lows-on-tuesday-4791824)
- 2023-07-25 16:32 UTC [Market Insight] [Dow Surges 50 Points; General Electric Profit Tops Expectations](https://www.quantisnow.com/insight/dow-surges-50-points-general-electric-profit-tops-expectations-4791821)
- 2023-07-25 13:59 UTC [Market Insight] [Nasdaq Rises 70 Points; General Motors Posts Upbeat Earnings](https://www.quantisnow.com/insight/nasdaq-rises-70-points-general-motors-posts-upbeat-earnings-4790663)
- 2023-07-25 13:05 UTC [Market Insight] [12 Health Care Stocks Moving In Tuesday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-tuesdays-pre-market-session-4790403)
- 2023-07-25 10:08 UTC [Market Insight] [Humanigen Said It Anticipates That It Will Not Be Able To Continue As A Going Concern And Is Exploring All Restructuring Options, Including Bankruptcy](https://www.quantisnow.com/insight/humanigen-said-it-anticipates-that-it-will-not-be-able-4788792)
- 2023-07-25 01:25 UTC [SEC Form 8-K] [Humanigen Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Leadership Update, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/humanigen-inc-filed-sec-form-8-k-notice-of-delisting-or-4788736)
- 2023-06-19 21:38 UTC [Market Insight] [12 Health Care Stocks Moving In Monday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-mondays-after-market-session-4656680)
- 2023-06-16 17:08 UTC [Market Insight] [Why Squarespace Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session](https://www.quantisnow.com/insight/why-squarespace-shares-are-trading-higher-by-around-7-here-4652239)
- 2023-06-16 13:08 UTC [Market Insight] [12 Health Care Stocks Moving In Friday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-fridays-pre-market-session-4651165)
- 2023-06-16 12:10 UTC [Market Insight] [Why Clene Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-clene-shares-are-trading-lower-by-20-here-are-4650801)
- 2023-06-13 20:05 UTC [Market Chatter] [Humanigen Granted U.S. Patent Titled 'METHOD OF INCREASING THE EFFICACY OF CAR-T IMMUNOTHERAPY USING LENZILUMAB'](https://www.quantisnow.com/insight/humanigen-granted-us-patent-titled-method-of-increasing-the-efficacy-4636523)
- 2023-05-15 10:02 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Humanigen Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-humanigen-inc-4499572)
- 2023-04-25 20:05 UTC [SEC Form 10-K] [SEC Form 10-K/A filed by Humanigen Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-10-ka-filed-by-humanigen-inc-amendment-4382198)
- 2023-04-19 10:07 UTC [Market Insight] [On April 18, 2023, Humanigen Was Notified That It Had Been Granted An Extension Until August 21, 2023 By Nasdaq To Demonstrate Compliance With All Applicable Requirements For Listing Of The Company's Common Stock](https://www.quantisnow.com/insight/on-april-18-2023-humanigen-was-notified-that-it-had-4352838)
- 2023-04-19 10:00 UTC [SEC Form 8-K] [Humanigen Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/humanigen-inc-filed-sec-form-8-k-other-events-financial-statements-4352793)
- 2023-04-14 16:07 UTC [Market Insight] [Humanigen Tweets 'Lenzilumab Being Studied As A Potential First Treatment In Thirty Years With A Novel Mechanism Of Action For Chronic Myelomonocytic Leukemia (CMML), An Orphan Form Of Leukemia'](https://www.quantisnow.com/insight/humanigen-tweets-lenzilumab-being-studied-as-a-potential-first-treatment-4336934)
- 2023-04-14 16:05 UTC [Humanigen - Lenzilumab Being Studied as a Potential First Treatment in Thirty Years with a Novel Mechanism of Action for Chronic Myelomonocytic Leukemia (CMML), an Orphan Form of Leukemia](https://www.quantisnow.com/insight/humanigen---lenzilumab-being-studied-as-a-potential-first-treatment-4336929)
- 2023-04-06 20:45 UTC [SEC Form 8-K] [Humanigen Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits](https://www.quantisnow.com/insight/humanigen-inc-filed-sec-form-8-k-notice-of-delisting-or-4310568)
- 2023-04-03 12:12 UTC [Market Insight] [Why Eastside Distilling Shares Are Trading Lower By Over 25%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-eastside-distilling-shares-are-trading-lower-by-over-25-4285675)
- 2023-04-03 11:33 UTC [Market Insight] [Credit Suisse Reiterates Underperform on Humanigen, Maintains $0.5 Price Target](https://www.quantisnow.com/insight/credit-suisse-reiterates-underperform-on-humanigen-maintains-05-price-target-4285217)
- 2023-03-30 21:24 UTC [SEC Form 10-K] [SEC Form 10-K filed by Humanigen Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-humanigen-inc-4275345)
- 2023-03-13 10:00 UTC [SEC Form 8-K] [Humanigen Inc. filed SEC Form 8-K: Regulation FD Disclosure](https://www.quantisnow.com/insight/humanigen-inc-filed-sec-form-8-k-regulation-fd-disclosure-4189823)
- 2023-03-06 21:31 UTC [Market Insight] [12 Health Care Stocks Moving In Monday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-mondays-after-market-session-4163864)
- 2023-03-02 22:15 UTC [SEC Form 8-K] [Humanigen Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/humanigen-inc-filed-sec-form-8-k-other-events-financial-statements-4155959)
- 2023-02-24 21:48 UTC [SEC Form 8-K] [Humanigen Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/humanigen-inc-filed-sec-form-8-k-notice-of-delisting-or-4117473)
- 2023-02-15 19:04 UTC [Market Insight] [Why Sabre Are Trading Lower By 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session](https://www.quantisnow.com/insight/why-sabre-are-trading-lower-by-19-here-are-other-4071218)
- 2023-02-15 13:05 UTC [Market Insight] [12 Health Care Stocks Moving In Wednesday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-wednesdays-pre-market-session-4068466)
- 2023-02-15 13:00 UTC [Market Insight] [Why TripAdvisor Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-tripadvisor-shares-are-trading-higher-by-10-here-are-4068402)
- 2023-02-14 21:31 UTC [Market Insight] [12 Health Care Stocks Moving In Tuesday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-tuesdays-after-market-session-4064048)
- 2023-02-14 20:59 UTC [Market Insight] [Humanigen Has Received A Notice Of Allowance For Its U.S. Patent Application 16/652,977 Titled "Methods Of Treating Immunotherapy-Related Toxicity Using A GM-CSF Antagonist".](https://www.quantisnow.com/insight/humanigen-has-received-a-notice-of-allowance-for-its-us-4062462)
- 2023-02-13 12:43 UTC [Market Insight] [Why Blue Apron Shares Are Trading Lower By 12%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-blue-apron-shares-are-trading-lower-by-12-here-4045124)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/HGEN
- Earnings history: https://www.quantisnow.com/earnings/HGEN
- Dividend history: https://www.quantisnow.com/dividends/HGEN
- Insider transactions: https://www.quantisnow.com/insiders/HGEN
- Options chain: https://www.quantisnow.com/options/HGEN
- SEC 8-K filings only: https://www.quantisnow.com/company/HGEN/8-k
- RSS and alerts for HGEN: https://www.quantisnow.com/docs/rss-feeds.md